Patent details
EP3160489 Title: CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CYSTITIS
Basic Information
- Publication number:
- EP3160489
- PCT Application Number:
- EP2015001294
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP157325333
- PCT Publication Number:
- WO2015197194
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CYSTITIS
- French Title of Invention:
- INHIBITEURS PEPTIDIQUES PERMÉABLES AUX CELLULES DE LA VOIE DE TRANSDUCTION DU SIGNAL JNK POUR LE TRAITEMENT DE LA CYSTITE
- German Title of Invention:
- ZELLDURCHLÄSSIGEN PEPTIDHEMMERN DES JNK-SIGNALTRANSDUKTIONSWEGES ZUR BEHANDLUNG VON ZYSTITIS
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 29/06/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 06/07/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 07/06/2023
- Unitary Effect Registration Date:
- 06/07/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 26/06/2015
- Grant date:
- 07/06/2023
- EP Publication Date:
- 03/05/2017
- PCT Publication Date:
- 30/12/2015
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/06/2023
- EP B1 Publication Date:
- 07/06/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 26/06/2035
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 31/05/2023
- Name:
- Xigen Inflammation Ltd.
- Address:
- Arch. Makariou III 195 Neocleous House, 3030 Limassol, Cyprus (CY)
Inventor
1
- Name:
- DELOCHE, Catherine
- Address:
- Switzerland (CH)
2
- Name:
- COMBETTE, Jean-Marc
- Address:
- France (FR)
Priority
1
- Priority Number:
- PCT/EP2014/001736
- Priority Date:
- 26/06/2014
- Priority Country:
- World Intellectual Property Office (WIPO) (WO)
2
- Priority Number:
- PCT/EP2014/002724
- Priority Date:
- 08/10/2014
- Priority Country:
- World Intellectual Property Office (WIPO) (WO)
Classification
- IPC classification:
- A61K 38/17; C07K 14/47; A61K 48/00; C07K 16/40; C12N 15/00; A61P 25/28; A61P 3/10; A61P 41/00; A61P 13/12; A61P 1/02; A61P 3/04; A61P 7/00; A61P 7/04; A61P 7/06; A61P 9/12; A61P 9/14; A61P 17/00; A61P 17/06; A61P 17/10; A61P 19/08;
Publication
European Patent Bulletin
1
- Issue number:
- 202323
- Publication date:
- 07/06/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202331
- Publication date:
- 02/08/2023
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202332
- Publication date:
- 09/08/2023
- Description:
- Unitary Effect Request Acceptance
4
- Issue number:
- 202340
- Publication date:
- 04/10/2023
- Description:
- Document reprinted after correction (B8, B9)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|